Not an Afterthought
Most investing education begins with the entry. The books, the courses, the frameworks — they teach how to identify quality businesses, how to assess valuation, how to time the purchase. The exit is treated as an obvious conclusion that either the market forces or a deteriorating business makes self-evident. When the business gets bad enough, you sell. When the price gets high enough, you sell. Both rules are presented as if they resolve themselves without much analytical effort.
They do not. A correct entry thesis with a poor exit discipline can still produce poor returns. The investor who identifies a great business, buys at a sound valuation, watches it rise significantly, and then holds through a complete deterioration of the underlying fundamentals has made two decisions — a good entry and a poor exit. The second decision erases much of the first. The exit deserves the same analytical rigour as the entry, and in most investment frameworks it receives far less.
Howard Marks has written more clearly about exit discipline than almost any other practitioner — in part because his framework for thinking about risk puts the permanent loss of capital at the centre of the analysis. Volatility is not the risk. Price decline is not the risk. The risk is the outcome from which there is no recovery.
"The most dangerous thing is the permanent loss of capital, not price volatility. The first is irreversible. The second is temporary."
Howard Marks · The Most Important Thing (2011) — paraphrase with attributionMarks's framework — extended here with the analytical discipline it implies — identifies three valid reasons to exit a position. They are worth examining individually because each requires a different analytical act, and each is harder to execute than it appears in the abstract.
The business has deteriorated in a way that invalidates the original analysis. Not that the price has fallen — that the fundamental case has changed. Revenue growth structurally slowing without a clear catalyst for reversal. A competitive advantage that was structural becoming vulnerable. Management capital allocation turning visibly destructive across several periods. The test is not "has the price gone down?" but "would I buy this business today, at the current price, with what I now know about it?" If the answer is no, and the reason is not valuation but business quality, the thesis is broken.
The price has run so far ahead of intrinsic value that the expected return from current levels, over any reasonable time horizon, is poor. This requires a discipline most investors do not exercise: estimating the forward return at the current price, not the purchase price. The investor who anchors to the price they paid — and judges whether the holding is "doing well" based on that reference — is asking the wrong question. The relevant question is: given what I know about this business today, what return does ownership from here offer? When the honest answer is unsatisfying, the holding is an opportunity cost, whether or not it has produced a gain from entry.
Capital committed to a position delivering 8–10% expected returns has an opportunity cost. When a demonstrably better-evidenced idea appears — one that has passed the same quality, valuation, and conviction tests — with materially higher expected returns, the allocation decision has analytical merit. This is not a licence for constant switching. It is a recognition that a portfolio is a finite resource, and the best use of that resource changes as the market presents new information.
The price has fallen by a specific percentage — this says nothing about whether the thesis is intact. The price has risen by a specific percentage — this says nothing about whether the expected return from here is still attractive. Someone else has sold — their thesis, their portfolio constraints, and their time horizon differ. None of these are analytical reasons to exit. They are reactions to market information that has been mistaken for fundamental information.
The Nifty 50 fell approximately 15–17% from its September 2024 peak to its trough in early 2025, over a period of roughly five months. The correction was driven primarily by foreign institutional outflows, a stronger dollar, and concerns about earnings growth decelerating following several years of strong recovery. Retail SIP inflows continued through this period — exceeding ₹20,000 crore per month across much of the drawdown.
For investors who held Indian large-cap equity through this period, the three exit tests applied as follows. The thesis — India's structural growth story, corporate earnings recovery, demographic tailwinds — had not changed. The business had not deteriorated. The correction had in fact improved the valuation case for continued ownership, reducing the 'Egregious Overvaluation' concern rather than confirming it. And no materially superior alternative had emerged that would justify switching from Indian equities to another asset class at that moment.
Investors who sold during the correction, citing the price decline itself as the reason, were selling on none of the three analytical grounds. They were selling because the price had moved — a reason that does not appear in Marks's framework. The investors who held, and continued their systematic investment plans through the drawdown, recovered the decline and moved to new highs in the months that followed.
The exit discipline required here was not analytical complexity — it was the application of the three-question test at the moment when market sentiment made the test feel unnecessary. That is precisely when it is most necessary.
The Nifty 50 is referenced for case study illustration purposes only and does not constitute an investment recommendation. Index levels and timing are approximate — verify before relying on any figure mentioned here.
Ramdeo Agrawal's QGLP framework provides the exit discipline implicitly through the structure of its entry framework. A business that continues to clear the Quality, Growth, and Longevity assessments — regardless of what has happened to the Price — remains, on the first three grounds, a hold. The exit signal arrives specifically when the Q gate is failed: when the quality assessment that justified entry is no longer valid.
The price going down is not a Q signal. It is a P signal that has moved in the wrong direction — which changes the attractiveness of additional buying and changes the urgency of the valuation review, but does not by itself invalidate the Q, G, or L assessments. The investor who sells a QGLP-clearing business because the price has fallen has conflated the P gate with the Q gate. They have exited because the market's short-term assessment has changed, not because their own fundamental assessment has changed.
The practical discipline Marks and Agrawal both point toward is the same: the exit decision requires running the original investment thesis forward and asking whether it remains valid at current conditions. Not whether the price has moved. Whether the thesis has moved.
The Through-Line
The exit is a second analytical act. It requires running the original thesis forward to ask whether the reasons you bought still apply — at the current price, with current business performance, against current alternatives. An investor who cannot answer that question cannot know whether to sell. An investor who answers it with reference to the price movement alone is answering the wrong question.
The three valid reasons to exit — broken thesis, egregious overvaluation, clearly superior opportunity — each require active analysis. The three false reasons — price down, price up, someone else sold — each require none. The discipline is distinguishing between them at the moment when the market makes the false reasons feel most compelling.
The entry thesis ages. The exit decision asks whether it has aged well or aged out.
The complete exit framework — with worked examples applied to Indian equities and the full Howard Marks risk philosophy — is inside the Investor Codex Learning Hub.
Explore the Learning HubThis newsletter is for educational purposes only. It does not constitute investment advice and should not be relied upon as the basis for any investment decision. Investor Codex is not registered with SEBI as a Research Analyst or Investment Adviser. All index and company references are for illustration purposes only and are not recommendations to buy or sell. Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal.